Trial intelligence / Profile preview

Doxycycline for vascular protection in circulatory shock

RBR-3gvnwgmPhase 3Recruiting

Sponsor
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
Start
Jun 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Shock comparing Doxycycline with Placebo (2 arms). Started Jun 2021; status: recruiting.

02

Drugs

doxycycline
03

Conditions

Shock

Beyond the preview

Go deeper on RBR-3gvnwgm.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-3gvnwgm.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call